We evaluated the correlation between aberrant HK2 expression and the clinicopathological features of EC patients in the Clinical Proteomic Tumor Analysis Consortium (CPTAC) datasets via the UALCAN database (http://ualcan.path.uab.edu/). The gene discussed is HK2; the disease is neoplasm.